Skip to main content

Part of the book series: Modern Otology and Neurotology ((MODOTOL))

  • 244 Accesses

Abstract

X-linked adrenoleukodystrophy (ALD) especially in childhood cerebral type is a metabolic degenerative disease with a severe clinical course of progressive deterioration until death involving progressive demyelination of the central nervous system caused by a defect in the ABCD1 gene at Xq28.

The frequency of hearing impairment has been reported in a rather high percentage of the patients but the other apparent deteriorating motor, mental, and visual symptoms are often concealed. Thus central auditory dysfunction is not fully recognized and it is difficult to support patients directly for their difficulties from their handicaps. These symptoms are due to the localized brain lesions but because of the character of disease, the lesions continuously and progressively expanded to the whole white matter of the brain without treatment.

The duration of apparent hearing impairment continued not so long in their natural history. Serial change could be evaluated clinically, nerophysiologically, and neurophysiologically.

There are some types of leukodystrophy but they usually progress rapidly in the brain and the lesion expansion is almost uniform. Therefore, it seems difficult to recognize symptoms based only on the localized brain lesions. Even during the clinical evaluation of an ALD patient, such symptoms may often be overlooked.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 119.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Furushima W, Inagaki M, Gunji A, Inoue Y, Kaga M, Mizutani S. Early signs of visual perception and evoked potentials in radiologically asymptomatic boys with X-LInked adrenoleukodystrophy. J Child Neurol. 2009;24:927−35.

    Google Scholar 

  • Furushima W, Kaga M, Nakamura M, Gunji A, Inagaki M. Auditory agnosia as a clinical symptom of childhood adrenoleukodystrophy. Brain Dev. 2015;37:690–7.

    Article  Google Scholar 

  • Inagaki M, Kaga Y, Kaga M, Nihei K. Multimodal evoked potentials in patients with pediatric leukodystrophy. Suppl Clin Neurophysiol. 2006;59:251–63.

    Article  Google Scholar 

  • Kaga K, Tokoro Y, Tanaka Y, Ushijima H. The progress of adrenoleukodystrophy as revealed by auditory brainstem evoked responses and brainstem histology. Arch Otorhinolaryngol. 1980;228:17–27.

    Article  CAS  Google Scholar 

  • Kaga M, Furushima W, Inagaki M, Nakamura M. Early neuropsychological signs of childhood adrenoleukodystrophy (ALD). Brain Dev. 2009;31:558−61.

    Google Scholar 

  • Kaga M, Nakamura M, Furushima W, Gunji A, Sakihara K, Inagaki M. Auditory function in patients with adrenoleukodystrophy. In: 11th European Paediatr Neurology Society Congress. May; Wien, AT. 2015.

    Google Scholar 

  • Moser HW, Loes DJ, Melhem ER, Raymond GV, Bezman L, Cox CS, et al. X-linked adrenoleukodystrophy: overview and prognosis as a function of age and brain magnetic resonance imaging abnormality. A study involving 372 patients. Neuropediatrics. 2000;31:277–39.

    Article  Google Scholar 

  • Moser HW, Smith KD, Watkins PA, Powers J, Moser AB. X-linked adrenoleukodystrophy. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease, vol. 2. 8th ed. New York: McGraw-Hill; 2001. p. 3257–301.

    Google Scholar 

  • Mosser J, Douar AM, Sarde CO, Kioschis P, Feil R, Moser H, et al. Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature. 1993;361:726–30.

    Article  CAS  Google Scholar 

  • Peters C, Charnas LR, Tan Y, Ziegler RS, Shapiro EG, DeFor T, et al. Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999. Blood. 2004;104:881–8.

    Article  CAS  Google Scholar 

  • Suzuki Y, Takemoto Y, Shimozawa N, Imanaka T, Kato S, Furuya H, et al. Natural history of X-linked adrenoleukodystrophy in Japan. Brain Dev. 2005;27:353–7.

    Article  Google Scholar 

  • Tanaka K, Naruto T, Yamamoto H, Nishizawa R, Izeki E, Shimada M. Early symptoms and signs of adrenoleukodystrophy. J Jpn Pediatr Soc. 1989;93:950–5. Japanese.

    Google Scholar 

  • Vogel BH, Bradley SE, Adams DJ, D’Aco K, Erbe RW, Fong C, Iglesias A, Kronn D, Levy P, Morrissey M, Orsini J, Parton P, Pellegrino J, Saavedra-Matiz CA, Shur N, Wasserstein M, Raymond GV, Caggana M. Newborn screening for X-linked adrenoleukodystrophy in New York State: diagnostic protocol, surveillance protocol and treatment guidelines. Mol Genet Metab. 2015;114:599–603.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Makiko Kaga .

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Science+Business Media Singapore

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Kaga, M. (2021). Adrenoleukodystrophy (ALD). In: Landau-Kleffner Syndrome and Central Auditory Disorders in Children. Modern Otology and Neurotology. Springer, Singapore. https://doi.org/10.1007/978-981-10-1479-6_8

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-1479-6_8

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-1478-9

  • Online ISBN: 978-981-10-1479-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics